Abstract
The ligand recognition site of A2a-adenosine receptors in rabbit striatal membranes was probed using non-site-directed labeling reagents and specific affinity labels. Exposure of membranes to diethylpyrocarbonate at a concentration of 2.5 mM, followed by washing, was found to inhibit the binding of [3H]CGS 21680 and [3H]xanthine amine congener to A2a receptors, by 86 and 30%, respectively. Protection from diethylpyrocarbonate inactivation by an adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine, and an antagonist, theophylline, suggested the presence of two histidyl residues on the receptor, one associated with agonist binding and the other with antagonist binding. Binding of [3H]CGS 21680 or [3H]xanthine amine congener was partially restored after incubation with 250 mM hydroxylamine, further supporting histidine as the modification site. Preincubation with disulfide-reactive reagents, dithiothreitol or sodium dithionite, at greater than 5 mM inhibited radioligand binding, indicating the presence of essential disulfide bridges in A2a receptors, whereas the concentration of mercaptoethanol required to inhibit binding was greater than 50 mM. A number of isothiocyanate-bearing affinity labels derived from the A2a-selective agonist 2-[(2-aminoethylamino) carbonylethylphenylethylamino]-5'-N- ethylcarboxamidoadenosine (APEC) were synthesized and found to inhibit A2a receptor binding in rabbit and bovine striatal membranes. Binding to rabbit A1 receptors was not inhibited. Preincubation with the affinity label 4-isothiocyanatophenylaminothiocarbonyl-APEC (100 nM) diminished the Bmax for [3H]CGS 21680 binding by 71%, and the Kd was unaffected, suggesting a direct modification of the ligand binding site. Reversal of 4-isothiocyanatophenylaminothiocarbonyl-APEC inhibition of [3H]CGS 21680 binding with hydroxylamine suggested that the site of modification by the isothiocyanate is a cysteine residue. A bromoacetyl derivative of APEC was ineffective as an affinity label at submicromolar concentrations.
MeSH Terms
Adenosine/analogs & derivatives,metabolism,pharmacology
Adenosine-5'-(N-ethylcarboxamide)
Affinity Labels
Amino Acid Sequence
Animals
Corpus Striatum/drug effects,metabolism
Diethyl Pyrocarbonate/pharmacology
Drug Antagonism
Hydroxylamine
Hydroxylamines/pharmacology
Molecular Sequence Data
Phenethylamines/metabolism
Purinergic Antagonists
Rabbits
Radioligand Assay
Receptors, Purinergic/chemistry,drug effects,metabolism
Theophylline/pharmacology
Xanthines/metabolism
Chemicals
Affinity Labels
Hydroxylamines
Phenethylamines
Purinergic Antagonists
Receptors, Purinergic
Xanthines
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
Hydroxylamine
Adenosine-5'-(N-ethylcarboxamide)
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine
Theophylline
Adenosine
Diethyl Pyrocarbonate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Jacobson K A
Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Stiles G L
Ji X D
References (24)
24 references, click to expand
-
Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.
J Pharmacol Exp Ther. 1991 Oct;259(1):286-94
PMID: 1920121
-
Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
Biochem Pharmacol. 1990 Aug 15;40(4):835-42
PMID: 2143656
-
Modification of histidyl residues in proteins by diethylpyrocarbonate.
Methods Enzymol. 1977;47:431-42
PMID: 22021
-
A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
Mol Pharmacol. 1992 Feb;41(2):352-9
PMID: 1311411
-
Adenosine A1 and A2 receptors: structure--function relationships.
Med Res Rev. 1992 Sep;12(5):423-71
PMID: 1513184
-
[(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.
Neurochem Int. 1991;18(2):207-13
PMID: 20504695
-
High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
Mol Pharmacol. 1988 Dec;34(6):724-8
PMID: 3200248
-
Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.
J Biol Chem. 1988 Nov 25;263(33):17522-6
PMID: 3182861
-
Probing the adenosine receptor with adenosine and xanthine biotin conjugates.
FEBS Lett. 1985 May 6;184(1):30-5
PMID: 2985445
-
Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):64-8
PMID: 2835689
-
Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6572-6
PMID: 2771944
-
Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
J Med Chem. 1989 May;32(5):1043-51
PMID: 2709373
-
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93
PMID: 2600819
-
Agonist derived molecular probes for A2 adenosine receptors.
J Mol Recognit. 1989 Dec;2(4):170-8
PMID: 2561548
-
Selective amplification and cloning of four new members of the G protein-coupled receptor family.
Science. 1989 May 5;244(4904):569-72
PMID: 2541503
-
Cardiovascular purinoceptors.
Physiol Rev. 1990 Jul;70(3):761-845
PMID: 2194223
-
Cloning and expression of an A1 adenosine receptor from rat brain.
Mol Pharmacol. 1991 Jul;40(1):1-7
PMID: 1857334
-
Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Bioconjug Chem. 1991 Mar-Apr;2(2):77-88
PMID: 1868116
-
The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
Mol Pharmacol. 1991 Feb;39(2):130-5
PMID: 1899902
-
Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
Mol Pharmacol. 1991 Nov;40(5):639-47
PMID: 1944235
-
Inhibition of muscarinic cholinergic receptors by disulfide reducing agents and arsenicals. Differential effect on locust and rat.
Biochem Pharmacol. 1991 Mar 1;41(5):735-42
PMID: 1998528
-
Evidence for the participation of histidine residues located in the 56 kDa C-terminal polypeptide domain of ADP-ribosyl transferase in its catalytic activity.
FEBS Lett. 1990 Oct 29;273(1-2):6-10
PMID: 2121544
-
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity.
Biochem Biophys Res Commun. 1990 Dec 31;173(3):1169-78
PMID: 2125216
-
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.
J Clin Invest. 1990 Apr;85(4):1150-7
PMID: 2156895